Table I.
Cells | Source | MICA | MICB | ULBP1 | ULBP2 | ULBP3 | ULBP4 |
---|---|---|---|---|---|---|---|
FaDu | HNSCC | + | + | − | + | + | − |
CAL27 | HNSCC | + | + | − | + | + | − |
PCI-15A | HNSCC | + | + | − | + | + | − |
Tu167 | HNSCC | + | + | − | + | + | − |
DM14 | HNSCC | + | + | − | − | + | − |
CaCo-2b | Colon | + | + | − | + | + | − |
HeLac | Cervical | + | Weak | − | Weak | Weak | − |
Jurkatd | T cell | + | + | + | + | − | − |
Cell surface NKG2D ligand expression, assessed by mAb staining and flow cytometry.
Colon adenocarcinoma.
Cervical adenocarcinoma.
T cell lymphoma/leukemia.